Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Integra Lifesciences Holdings (IART) Shares Outstanding (Diluted Average) (2016 - 2025)

Integra Lifesciences Holdings' Shares Outstanding (Diluted Average) history spans 17 years, with the latest figure at $76.7 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) changed 0.44% year-over-year to $76.7 million; the TTM value through Dec 2025 reached $76.7 million, changed 0.44%, while the annual FY2025 figure was $76.7 million, 0.44% changed from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $76.7 million at Integra Lifesciences Holdings, roughly flat from $76.6 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $85.5 million in Q4 2021 and bottomed at $76.5 million in Q1 2025.
  • The 5-year median for Shares Outstanding (Diluted Average) is $81.4 million (2023), against an average of $80.9 million.
  • The largest annual shift saw Shares Outstanding (Diluted Average) grew 0.73% in 2021 before it dropped 5.57% in 2024.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $85.5 million in 2021, then decreased by 2.3% to $83.5 million in 2022, then fell by 3.81% to $80.3 million in 2023, then fell by 4.14% to $77.0 million in 2024, then dropped by 0.44% to $76.7 million in 2025.
  • Per Business Quant, the three most recent readings for IART's Shares Outstanding (Diluted Average) are $76.7 million (Q4 2025), $76.6 million (Q3 2025), and $76.6 million (Q2 2025).